Difference between revisions of "Lu J, et al. Oncogene (2017) cited as Ref 211 in DOI: 10.1038/s41392-020-0110-5 (Q9474)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 36, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1 (English) | ||
| Property / title: MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1 (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:54, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Lu J, et al. Oncogene (2017) cited as Ref 211 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Lu J
0 references
2017
0 references
Oncogene
0 references
36
0 references
MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1 (English)
0 references
